Institutional shares held 56.5 Million
79.3K calls
20.3K puts
Total value of holdings $89.8M
$126K calls
$32K puts
Market Cap $22.4M
14,634,400 Shares Out.
Institutional ownership 386.13%
# of Institutions 74


Latest Institutional Activity in RGLS

Top Purchases

Q3 2024
Nea Management Company, LLC Shares Held: 6.47M ($9.9M)
Q3 2024
Price T Rowe Associates Inc Shares Held: 2.15M ($3.29M)
Q3 2024
Point72 Asset Management, L.P. Shares Held: 894K ($1.37M)
Q3 2024
Northern Trust Corp Shares Held: 497K ($761K)
Q3 2024
Td Asset Management Inc Shares Held: 302K ($462K)

Top Sells

Q3 2024
Ra Capital Management, L.P. Shares Held: 767K ($1.17M)
Q3 2024
Opaleye Management Inc. Shares Held: 535K ($819K)
Q3 2024
Geode Capital Management, LLC Shares Held: 1.28M ($1.96M)
Q3 2024
Monashee Investment Management LLC Shares Held: 147K ($225K)
Q3 2024
Renaissance Technologies LLC Shares Held: 97.2K ($149K)

About RGLS

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.


Insider Transactions at RGLS

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
307K Shares
From 5 Insiders
Grant, award, or other acquisition 303K shares
Open market or private purchase 4K shares
Sell / Disposition
25.5K Shares
From 3 Insiders
Open market or private sale 25.5K shares

Track Institutional and Insider Activities on RGLS

Follow Regulus Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGLS shares.

Notify only if

Insider Trading

Get notified when an Regulus Therapeutics Inc. insider buys or sells RGLS shares.

Notify only if

News

Receive news related to Regulus Therapeutics Inc.

Track Activities on RGLS